Premium
Susceptibility and trailing growth of Candida albicans to fluconazole: results of a Korean multicentre study
Author(s) -
Lee MiKyung,
Kim HyeRyoun,
Kang JungOak,
Kim MiNa,
Kim EuiChong,
Kim JaeSeok,
Kim JinJu,
Park YeonJoon,
Song Wonkeun,
Shin JongHee,
Lee KyuMan,
Lee NamYong,
Lee Miae,
Lee WeeGyo,
Lee Chang Kyu,
Lee HeeJoo,
Chang Chulhun L.,
Choi Tae Yeal
Publication year - 2007
Publication title -
mycoses
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.13
H-Index - 69
eISSN - 1439-0507
pISSN - 0933-7407
DOI - 10.1111/j.1439-0507.2006.01329.x
Subject(s) - fluconazole , candida albicans , medicine , microbiology and biotechnology , antifungal , biology
Summary The work reported here is the first nationwide, multicenter surveillance study conducted in Korea to obtain data on fluconazole susceptibility of Candida albicans ( C. albicans ) isolates. A total of 1137 isolates of C. albicans obtained from 17 university hospitals in South Korea during the 6‐month period, July through December 2004, were tested. No resistant strains were observed in any of the isolates. Only five of the 1137 isolates (0.44%) of C. albicans were found to be susceptible dose dependent, with all remaining strains (99.56%) susceptible to fluconazole. Trailing growth at 48 h was found in only four isolates (0.35%).